Home > Annual Financials > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS Financial Statement Analysis
[BOM: 539997]

The Revenues of KWALITY PHARMACEUTICALS have decreased by -44.97% YoY .
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has decreased by -83.86 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KWALITY PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539997]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹251 Cr₹456 Cr₹262 Cr₹139 Cr₹166 Cr
Expenses ₹190 Cr₹285 Cr₹233 Cr₹125 Cr₹151 Cr
Operating Profit (Excl OI) ₹61 Cr₹172 Cr₹29 Cr₹14 Cr₹16 Cr
Other Income ₹2.94 Cr₹3.51 Cr₹1.59 Cr₹3.66 Cr₹0.61 Cr
Interest ₹6.61 Cr₹2.92 Cr₹2.68 Cr₹2.53 Cr₹2.29 Cr
Depreciation ₹15 Cr₹11 Cr₹6.49 Cr₹4.43 Cr₹3.12 Cr
Profit Before Tax ₹26 Cr₹162 Cr₹21 Cr₹11 Cr₹11 Cr
Profit After Tax ₹19 Cr₹120 Cr₹15 Cr₹8.21 Cr₹7.56 Cr
Consolidated Net Profit ₹19 Cr₹120 Cr₹15 Cr₹8.32 Cr₹7.55 Cr
Earnings Per Share (Rs)₹18.67₹115.64₹14.60₹8.02₹7.28
PAT Margin (%)7.6826.295.685.894.54
ROE(%)10.1599.6628.2120.1023.13
ROCE(%)12.0695.3226.3618.4921.91
Total Debt/Equity(x)0.450.350.680.770.79

Key Financials

Market Cap : ₹ 513.2 Cr
Revenue (TTM) : ₹ 284.0 Cr
Net Profit(TTM) : ₹ 11.9 Cr
EPS (TTM) : ₹ 11.4
P/E (TTM) : 43.1

Industry Peers & Returns1W1M1Y
KWALITY PHARMACEUTICALS -2.7% 14.9% 35.6%
SUN PHARMACEUTICAL INDUSTRIES 0.3% -7.5% 53.9%
CIPLA 1.1% -4.8% 56.4%
DR REDDYS LABORATORIES 1.6% 1.6% 27.6%
ZYDUS LIFESCIENCES 5.2% -0.2% 90.1%
DIVIS LABORATORIES -1.9% 10.7% 21.4%
MANKIND PHARMA -2.3% 0.1% NA
TORRENT PHARMACEUTICALS 1.6% 2% 61.8%
LUPIN 2.4% 2% 132.5%


KWALITY PHARMACEUTICALS Revenues
[BOM: 539997]

Y-o-Y

-44.97 %

5 Yr CAGR

10.84 %

Years Revenues % Change
Mar2023 ₹251 Cr
-44.97
Mar2022 ₹456 Cr
74.11
Mar2021 ₹262 Cr
88.10
Mar2020 ₹139 Cr
-16.23
Mar2019 ₹166 Cr -


KWALITY PHARMACEUTICALS Operating Profit
[BOM: 539997]

Y-o-Y

-64.62 %

5 Yr CAGR

40.21 %

Years Operating Profit % Change
Mar2023 ₹61 Cr
-64.62
Mar2022 ₹172 Cr
494.81
Mar2021 ₹29 Cr
103.01
Mar2020 ₹14 Cr
-9.54
Mar2019 ₹16 Cr -

Operating Margins
Y-o-Y

-35.72 %

5 Yr CAGR

26.49 %

Years Operating Margin% % Change
Mar2023 24.19%
-35.72
Mar2022 37.63%
241.78
Mar2021 11.01%
7.84
Mar2020 10.21%
8.04
Mar2019 9.45% -

KWALITY PHARMACEUTICALS Profit After Tax
[BOM: 539997]

Y-o-Y

-83.85 %

5 Yr CAGR

26.56 %

Years Profit After Tax % Change
Mar2023 ₹19 Cr
-83.85
Mar2022 ₹120 Cr
692.23
Mar2021 ₹15 Cr
82.11
Mar2020 ₹8.32 Cr
10.13
Mar2019 ₹7.55 Cr -

PAT Margins
Y-o-Y

-70.79 %

5 Yr CAGR

14.05 %

Years PAT Margin(%) % Change
Mar2023 7.68 %
-70.79
Mar2022 26.29 %
362.85
Mar2021 5.68 %
-3.57
Mar2020 5.89 %
29.74
Mar2019 4.54 % -

KWALITY PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539997]

Y-o-Y

-83.86 %

5 Yr CAGR

26.55 %

Years EPS % Change
Mar2023 ₹19
-83.86
Mar2022 ₹116
692.05
Mar2021 ₹15
82.04
Mar2020 ₹8.02
10.16
Mar2019 ₹7.28 -

KWALITY PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539997]

Y-o-Y

-87.35 %

5 Yr CAGR

-13.87 %

Years ROCE % Change
Mar2023 12.06%
-87.35
Mar2022 95.32%
261.61
Mar2021 26.36%
42.56
Mar2020 18.49%
-15.61
Mar2019 21.91% -

KWALITY PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹493.5
Current MarketCap: ₹ 513.2 Cr
Updated EOD on :May 03,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-2.7%

14.9%

35.6%

SENSEX

-0.6%

0.3%

21.8%

KWALITY PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KWALITY PHARMACEUTICALS Financials


How the annual revenues of KWALITY PHARMACEUTICALS have changed ?

The Revenues of KWALITY PHARMACEUTICALS have decreased by -44.97% YoY .

How the Earnings per Share (EPS) of KWALITY PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has decreased by -83.86 % YoY .